Drug Release Mechanism of Slightly Soluble Drug from Nanocomposite Matrix Formulated with Zeolite/ Hydrotalcite as Drug Carrier by Ainurofiq, A & Choiri, S
Ainurofiq & Choiri 
Trop J Pharm Res, July 2015; 14(7): 1129  
 
Tropical Journal of Pharmaceutical Research July 2015; 14 (7): 1129-1135 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v14i7.2 
Original Research Article 
 
 
Drug Release Mechanism of Slightly Soluble Drug from 
Nanocomposite Matrix Formulated with Zeolite/ 
Hydrotalcite as Drug Carrier 
 
Ahmad Ainurofiq1* and Syaiful Choiri1,2  
1Department of Pharmacy, Sebelas Maret University, Ir.Sutami No. 36A, Surakarta, 57126, Indonesia, 2School of Pharmacy, 
Institut Teknologi Bandung, Ganesha 10, Bandung, 40132, Indonesia 
*For correspondence: Email: rofiq@mipa.uns.ac.id; Tel: +6271663375, +628156672276; Fax: +6271663375 
 
Received: 2 February 2015        Revised accepted: 12 June 2015 
 
Abstract 
Purpose: To evaluate the mechanism of drug release of a slightly soluble drug (theophylline) from 
nanocomposite of zeolite (ZLT) or hydrotalcite (HTC) used as drug carrier.  
Methods: Nanocomposite was prepared with dispersion of either ZLT or HTC as drug carrier and 
theophylline (THP) as drug in drug to clay ratios of 1:2, 3:4 and 1:1. The formulations were 
characterized for drug release and loading. Dependent and independent kinetic models were employed 
to analyze the drug release data. Fourier transform infrared spectroscopy (FTIR) was used for the 
structural characterization of the formulations. 
Results: Nanocomposite was formed due to incorporation of the drug in the basal spacing of ZLT/HTC. 
The drug loading of THP/ZLT and THP/HTC composites were 38.10 % for 2 h and 27.35 % for 3 h, 
respectively. HTC and ZLT nanocomposite retarded drug release for 6 h. Non-linear and Peppas-Sahlin 
were the best fitting kinetic release models based on the goodness of fit.  
Conclusion: ZLT provides better drug loading capacity than HTC. However, both ZLT and HTC are 
suitable for the formulation of controlled release products. The drug release kinetics and mechanism 
were a combination of Fickian and non-Fickian diffusion. 
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Controlled drug delivery systems using clays, 
such as mesoporous silica, have been reported 
extensively by several researchers [1–3]. Zeolite 
(ZLT) and hydrotalcite (HTC) are composed of 
layers of large and insoluble cations, those are 
weakly bound to the space between interlayers 
[4]. Some properties of the clays include 
swellability, cation/anion exchange and 
intercalation. These properties make them 
promising candidate in development of drug-
nanoclay composites for controlled release drug 
delivery systems [5,6]. ZLT and HTC have large 
pores and drug as guest molecules can be 
loaded into the nanoporous structure [7]. The 
nanopores are knew as basal spacing which 
nanocomposite can be formed naturally [8].  
 
ZLT has smaller pores than mesoporous material 
that its characteristic can be used to achieve 
controlled release effectively. The drug as guest 
molecules can be loaded into pores depending 
on the size of the mesopores. Adsorption and 
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release of molecules from this matrix are 
governed by size selectivity and a pore size of 
the order of the drug dimension provides a better 
control of drug release [9]. Nano composite has 
been successfully produced between drug and 
ZLT combined with biodegradable polymers (i.e. 
chitosan, gelatin and alginate) and prolonged the 
drug releases [10]. Diclofenac sodium has been 
loaded into natural ZLT and the drug released for 
8 h [11]. 
 
HTC (anionic clay) is a two-dimensional layered 
double hydroxides material. This material is 
natural HTC with the brucite structure, where for 
each set of eight magnesium cations, substituted 
by two aluminum cations. The positive charge in 
excess is balanced by carbonate anions hosted 
together with water molecules in the interlayer 
[12]. The intercalation of this anionic clay and its 
high affinity for carbonate ion in acid medium 
makes it able to load the drug in the interlayers. 
HTC has been developed as a drug carrier using 
ketoprofen, sodium diclofenac and 
chloramphenicol succinate drug release up to 24 
h [13,14]. HTC was used as controlled release 
formulation using poorly water-soluble drug and 
released the drug in a controlled release manner 
in intestinal environment [15]. 
 
The purpose of the present study was to 
evaluate the drug release models of nanoclays-
based matrix drug carriers of slightly water-
soluble drug using ZLT and HTC to formulate 






Theophylline (THP; Shandong Pharm, China), 
lactose (DFE Pharma, The Netherlands), 
magnesium stearate (Peter Greven, Germany) 
were purchased from local suppliers, natural ZLT 
was obtained from Gunung Kidul (Yogyakarta, 
Indonesia), HTC was obtained from Sigma 
Aldrich (Singapore) and used as received, 
hydrochloric acid,  dibasic potassium phosphate 
and sodium hydroxide were purchased form 
Merck (Darmstadt, Germany) and demineralized 
water. All the following chemicals were of 
analytical grade. 
 
Preparation of ZLT 
 
ZLT was washed with demineralized water and 
colloid phase was precipitated overnight. The 
precipitation was washed 3 times, then filtered 
with a vacuum filter and dried in oven at 110 oC 
for 6 h. Activation was done to open the pores of 
ZLT using 500 mL of HCl (1 mol/L) was refluxed 
for 5 h at 90 oC and then washed with 
demineralized water until the pH became neutral. 
The ZLT was washed with 0.75 mol/L NaOH 500 
mL to build proportion of silica and aluminum and 
then with demineralized water until pH became 
neutral. Furthermore, it was precipitated 
overnight and filtered with a vacuum filter and the 
residue was dried in oven at a temperature of 
110 oC for 6 h. The dried ZLT was passed 
through 180 mesh sieve (80 µm). 
 
Composites of THP/ZLT and THP/HTC 
 
The composite between THP and clays were 
prepared by dispersing 5 % (w/v) ZLT or HTC in 
50 mL aqueous medium containing of 250 mg 
THP. The mixtures were stirred at 600 rpm for 4 
h at ambient temperature to achieve equilibrium 
composite between drug and ZLT/HTC. Two mL 
samples were withdrawn every 30 min and 
centrifuged at 6000 rpm for 2 min using Thermo 
Scientific Heraeus centrifuge. The supernatant 
was analyzed using Hitachi U-2900 
Spectrophotometer at wavelength 271.5 nm. The 
sediment from centrifugation was dried in oven at 
60 oC for 6 h and stored in desiccator until further 
analysis. Drug loading (DL) was computed as in 
Eq 1. 
 
DL (%) = {(W1 – W2)/W1}100 …..…………… (1) 
 
where W1 is the initial concentration of drug and 
W2 the concentration of drug after composite 
formulation. 
 
FTIR spectroscopy studies 
 
The nanocomposite was characterized using 
FTIR Shimadzu 8400S (Kyoto, Japan) to 
determine the composite between THP and 
clays. THP, ZLT, HTC, THP/ZLT and THP/HTC 
were scanned using potassium bromide pellets in 
the range of wavenumber 4000 – 400 cm-1 with 
resolution 4 cm-1 and 10 times iteration. The 
pellets were prepared using 150 mg potassium 
bromide and 1.5 mg of samples were mixed 
homogenously and pressed by a hydraulic 
pressure at 60 kN for 5 min. 
 
Preparation of THP tablets 
 
The tablet formulations are presented in Table 1.  
Magnesium stearate (1 % of the tablet weight) 
and lactose were used as lubricant and filler, 
respectively. All the ingredients except the 
lubricant were mixed homogenously using mixer 
(25 rpm) for 16 min. Demineralized water were 
added until a wet mass of granules was 
achieved. The wet granules mass were passed 
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through 16 mesh sieve (1.18 mm) and dried in an 
oven at 50 oC for 3 h. The dried granules were 
passed through 18 mesh sieve (1.00 mm). The 
granules were evaluated for particle size 
distribution using Retsch AR200 basic analytical 
sieving, moisture content was done using Ohaus 
EB-340 moisture analyzer balance. The dried 
granules and magnesium stearate were mixed 
using mixer (25 rpm) for 4 min. Further 
characterization of granules was conducted to 
determine flow time, angle of repose and 
compactibility with deepness of upper and lower 
punch at 5.30 and 8.15 mm, respectively. 
 
The granules were compressed into tablets. The 
weight of tablet was adjusted 500 mg and the 
hardness was kept at 100 – 120 N and tested by 
Gouming YD-01 hardness tester. 
 
Table 1: Composition of the formulated tablets 
 
Batch Composition (% w/w) Theophylline Zeolite Hydrotalcite 
F1 40 - - 
F2 40 20 - 
F3 40 30 - 
F4 40 40 - 
F5 40 - 20 
F6 40 - 30 
F7 40 - 40 
 
Drug release study 
 
Drug release testing was performed using 
Electrolab TDT-08L dissolution tester model USP 
apparatus type II with 75 rpm speed rotation and 
temperature was maintained at 37 ± 0.5 oC. A 
900 mL phosphate buffer pH 4.5 was used as 
dissolution medium. Ten milliliters of aliquots 
were withdrawn at different times i.e. 15, 30, 45, 
60, 90, 120, 180, 240 and 360 min. The medium 
was replaced with equivalent volume of fresh 
medium to maintain constant volume and sink 
condition. Aliquots were analyzed using Hitachi 





The data were analyzed statistically by one-way 
ANOVA (p < 0.05) and, if significantly different, 
also by t-LSD. Drug release profiles were 
compared with a marketed extended-release 
product (MP) of THP using similarity factor (f2). 
Drug release data were computed with free open 
source software KinetDS® [16] and DDSolver® 
[17]. Several mathematic models were applied to 
determine and describe the drug releases from 
nanoclay-based matrix i.e. zero-order, first-order, 
Higuchi, Hixson-Crowell, quadratic and Peppas-
Sahlin equation. The best fitting model based on 
coefficient of determination (R2) and AIC 
(Akaike’s information criterion). Weibull model 
was used to determine the shape of curve 
release based on shape parameter curve (β), the 
mechanism of drug release was determined by 
diffusion exponential value (n) of Korsmeyer-




Fig 1 showed the drug loading kinetics of 
THP/ZLT and THP/HTC. The ZLT showed higher 
drug loading after 1.5 h, at initial time the HTC 
provided better drug loading than ZLT, all of the 
drug loading kinetic profiles showed that 
reducing of drug loading overtime after 3 h for 
HTC and 2 h for ZLT. 
 
 
Figure 1: Drug loading kinetics of THP/Clays 
 
The FTIR spectrum of THP and composites are 
presented in Fig. 2. The principal peaks of THP 
were at wavenumber 1716.65 cm-1 and 1666.50 
cm-1 assigned carbonyl asymmetric and 
symmetric vibration respectively. The peaks at 
wavenumber 1566.20 cm-1 assigned C=N 
vibration and 1188.15 cm-1 assigned C-N 
vibration. The peaks at wavenumber around 
1400 – 1500 cm-1 assigned ring stretching 
vibration and 3120.82 cm-1 assigned N-H 
stretching vibration. 
 
The physical properties of granules are 
presented in Table 2. The ZLT had higher tapped 
and bulk density than HTC. Increasing ZLT 
concentration gave no significant difference in 
bulk and tapped density (p > 0.05), while 
increasing HTC concentration reduced 
significantly the tapped, bulk density and 
compaction ability (p < 0.05). The moisture 
content of ZLT was higher than that of HTC 
ranging from 1.0 – 1.83 % and 0.30 – 0.83 %, 
respectively. The flowability was shown by flow 
time and angle of repose which less than 7 sec 
and 29o, respectively. 
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Figure 2: FTIR spectra of THP (a), ZLT (b), HTC (c), THP/ZLT (d), and THP/HTC composite (e) 
 
 
Table 2: Physicochemical properties of formulation granules 
 













F1 0.546±0.007 0.642±0.002 0.30±0.00 5.78±0.25 94.7±3.2 24.71±0.71 
F2 0.612± 0.012 0.707±0.003 1.00±0.00 5.39±0.37 97.9±9.5 26.65±0.80 
F3 0.600±0.009 0.700±0.009 1.30±0.00 4.72±0.23 120.5±7.7 26.84±0.29 
F4 0.612±0.004 0.712±0.004 1.83±0.29 5.09±0.27 124.7±11.9 25.69±1.22 
F5 0.571±0.000 0.682±0.007 0.30±0.00 5.74±0.15 78.3±7.0 25.81±0.46 
F6 0.488±0.000 0.591±0.010 0.30±0.00 6.07±0.15 43.8±0.63 27.27±1.41 




Figure 3: THP release profile from ZLT and HTC nanocomposites ( –♦– (F1), –○– (F2), –∆– (F3), –□– (F4), - -●- -  
(F5), - -▲- - (F6), - -■- - (F7) and ∙∙∙∙×∙∙∙∙ (MP) 
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The drug release profiles of ZLT and HTC are 
presented in Fig. 3. The drug release of ZLT 
matrix was higher than that of HTC. The different 
matrix concentration provided similarity of 
release pattern. The formulation without matrix 
showed that the drug released completely after 4 
h and addition of ZLT and HTC extended the 
drug release up to 6 h. The hardness and weight 
of tablet was not significant difference statistically 
(p > 0.05). Comparison of the drug release 
profiles using dissolution efficiency during 6 h 
(DE6h) and mean dissolution time (MDT) of ZLT 
and HTC under different concentrations provided 
no significant difference of DE6h and MDT (p > 
0.05) and similarity factor was less than 50. 
 
The drug kinetics models are presented in Table 
4. The best fitting of models was based on 
goodness of fit i.e. the highest R2 and lowest AIC 
values. Zero-order release kinetics presented 
drug release rate (k) and intercept (F0). 
Increasing ZLT concentration reduced k and 
increased F0, on the other hand increasing HTC 
concentration increased k and reduced F0. The 
F3-F5 followed linear model and F2, F6 and F7 
followed nonlinear model. Peppas-Sahlin model 
was the best fitting for all formulations followed 
by Weibull, Quadratic, Higuchi, first-order and 
zero-order release model. The different 
formulations showed different of drug release 
kinetics. Increasing ZLT concentration increased 
the exponential diffusion value of Peppas-Sahlin 
model and increasing of HTC reduced the 
exponential diffusion value of Peppas-Sahlin. 
 
 
Table 3: Physical properties of THP tablet and the release rate 
 
Batch Hardness (N) Weight variation (mg) DE6h (%) 
MDT 
(min) f2 
F1 110.4±6.6 510.1±5.95 81.85 65.39 2.47 
F2 112.0±8.7 511±13.73 48.43 122.43 32.27 
F3 109.7±5.3 510±12.14 48.83 129.03 30.33 
F4 109.4±5.2 510±14.87 48.88 105.12 28.87 
F5 111.4±5.7 506.5±5.3 32.13 134.25 39.06 
F6 115.0±10.8 504.3±3.1 32.88 138.27 42.32 
F7 114.6±8.8 508.1±5.2 35.29 142.96 48.57 
 
     Table 4: Drug release kinetics and mechanism of nanoclays-based matrix 
 
Model Kinetic parameter F2 F3 F4 F5 F6 F7 
Zero-order  
R2 0.968 0.968 0.933 0.972 0.978 0.971 
k (mg/min) 0.386 0.352 0.338 0.251 0.282 0.321 
F0 (%) 12.90 16.49 17.73 9.40 6.46 4.90 
AIC 54.77 53.01 59.90 45.03 44.64 50.29 
First-order R
2 0.983 0.941 0.927 0.914 0.982 0.983 
AIC 46.78 57.17 58.86 54.17 40.81 42.86 
Higuchi R
2 0.967 0.989 0.987 0.961 0.934 0.891 
AIC 53.16 40.38 41.45 46.12 53.75 61.38 
Hixson-Crowell R
2 0.960 .896 0.863 0.887 0.968 0.978 
AIC 55.09 62.80 65.14 56.85 46.50 45.39 
Quadratic R
2 0.978 0.942 0.962 0.940 0.992 0.985 
AIC 51.26 58.94 54.18 52.53 35.24 43.82 
Peppas-Sahlin 
R2 0.995 0.995 0.998 0.983 0.993 0.980 
k1 -9.059 2.777 1.678 2.010 -2.316 -2.003 
k2 7.401 -0.007 -0.010 0.082 2.048 1.526 
M 0.232 0.573 0.726 0.469 0.297 0.330 
AIC 37.80 37.46 26.81 41.93 35.20 48.43 
Weibull 
R2 0.994 0.993 0.997 0.981 0.995 0.984 
Β 1.84 2.24 1.15 2.30 1.38 2.79 
AIC 39.51 39.67 31.83 42.92 32.56 46.22 
Korsmeyer-
Peppas 
R2 0.994 0.994 0.988 0.982 0.993 0.979 
N 0.622 0.549 0.518 0.606 0.704 0.777 
AIC 38.50 35.58 42.79 40.48 34.01 46.77 
  k1 = constant of Fickian diffusion, k1 = constant of non-Fickian diffusion, m = exponential diffusion of Peppas-
Sahlin equation 
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Preliminary study revealed that nanocomposite 
between THP as drug model with slightly water-
soluble drug and clays (ZLT and HTC) had ability 
to load the drug into the pores. The drug loading 
shows the abilities of the clays to load the drug 
as guest molecules into the pores. The drug 
loading using ZLT and HTC as clays and THP as 
drug studied for the time dependent is presented 
in Fig. 1. Among both of clays, the ZLT showed 
better drug loading than HTC. Overall, the drug 
loading of THP/ZLT and THP/HTC decreased 
with increasing of composite time, thus indicated 
the interaction between the clays and drug as 
reversible interaction.  
 
The FTIR spectra of composite between THP 
and ZLT or HTC are shown in Fig. 2, there was 
the composite spectra followed the native of ZLT 
or HTC spectra, hence it was no significant 
change of the native clay spectra and 
disappearance of THP spectra, these indicated 
the interaction between drug and ZLT/HTC and 
the drug loaded into nanoporous of ZLT/HTC. 
 
Based on the results of the physical properties of 
granules are presented in Table 2,  the granules 
using ZLT and HTC as matrices had good fluidity 
and compaction ability. Improving concentration 
of ZLT, increased the compaction ability and 
fluidity, although improving concentration of HTC, 
decreased the fluidity and compaction ability. 
The desirable flow time for 100 grams of granule 
was less than 10 sec and angle of repose less 
than 30o [18]. The flowability was affected by 
some factors such as moisture, density, particle 
size distribution, porosity and cohesiveness 
between the particles. The test result of particle 
size distribution showed that particle size 
distributed normally and fines of granule were 
less than 10 % (data not shown). Compaction 
ability was described from crushing force of 
tablet, the higher of compactibility value of 
granule mass, will make it easily compressible 
and produce compact mass with relatively low 
pressure. Weight of tablets ranged from 504.3 to 
511 mg with low standard deviation.  
 
The drug release profiles from controlled release 
tablets are shown in Fig 3. The drug release 
profile showed that HTC matrix released THP 
slower than the ZLT matrix. The drug loaded into 
the nanoporous of the nanoclays (ZLT and HTC), 
controlled drug release in these matrices are 
governed by size selectivity and pore size [12]. 
The different concentrations of ZLT and HTC 
matrix showed no significant difference on DE360 
and MDT (p > 0.05). Increasing of the ZLT 
concentration showed no significant difference in 
DE360 and decreasing of MDT (p > 0.05), 
moreover increasing the HTC concentration 
significantly increased MDT (p < 0.05). The drug 
release from tablet using HTC and ZLT as matrix 
was retarded and released up to 6 h. It was 
indicated by decreasing DE6h and increasing 
MDT. f2 value for all the formulations were less 
than 50, thus the drug release profiles different 
from marketed product release profiles [19]. The 
ZLT as clay-based matrix, increasing the 
concentrations decreased the f2 value. The ZLT 
as matrix showed the initial burst release effect 
was shown by intercept of zero order release 
(F0), increasing of ZLT concentration increased 
the drug release at initial time. The release rate 
of marketed product formulation no significant 
difference with THP/ZLT nanocom-posite 
formulation (p > 0.05), the different release 
profiles was affected by amount of drug release 
at initial time, the ZLT released higher amount of 
drug than HTC at initial time, but the marketed 
product formulation released the drug with 
constant rate (followed zero-order release). 
 
The THP/HTC nanocomposite tablet formulation 
showed that increasing HTC concentrations 
increased the f2 value and decreased the drug 
release at initial time. Different drug release 
profiles between marketed product formulation 
and THP/HTC nanocomposite formulation were 
affected by a decrease the release rate of HTC 
nanocomposite after 3 h. The drug bounded in 
the interlayer of clays, thus the drug released 
slowly. The HTC has limitation in wettability, thus 
reduced and avoided the initial burst release 
effect. The release profile in initial time of HTC 
formulation showed similarity with marketed 
formulation, although after 2 h burst release 
effect was shown. The release rate after 4 h 
decreased constantly. ZLT and HTC as matrix 
showed initial burst release effect using freely 
water-soluble drug as drug model [20]. The 
exponential value between 0.45 to 0.89 indicate 
that THP release from nanoclays (HTC and ZLT) 
was governed by diffusion and erosion of the 
matrices.  
 
Based on the drug releases kinetic and 
mechanism models are presented in Table 4, 
THP release kinetic of nanoclay matrices could 
be described by the Peppas-Sahlin model’s with 
the highest coefficient of determination and 
lowest of AIC value. Peppas and Sahlin model 
describe the drug release in combination of 
Fickian diffusional contribute with non-Fickian 
one in a linear manner [21,22], thus the drug 
release from nanocomposite of the ZLT or HTC 
followed combination Fickian and non Fickian 
release mechanism. 
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Both HTC and ZLT are potential drug carriers 
and capable to load the drug as guest molecule 
into the pores in reversible interaction and time 
dependent. The HTC provided drug release more 
retardant than ZLT as matrix, drug releases 
under different concentrations were to be found 
no statistically different from one another of both 
matrices. The kinetics of drug releases followed 
Peppas-Sahlin model and linear model. The 
mechanism of drug releases were anomalous 
transport which combines Fickian and non-
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